This is a PDF file of a peer-reviewed paper that has been accepted for publication. Although unedited, the content has been subjected to preliminary formatting. Nature is providing this early version of the typeset paper as a service to our authors and readers. The text and figures will undergo copyediting and a proof review before the paper is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.

Aging is a predominant risk factor for numerous chronic diseases that limit healthspan 1. Mechanisms of aging are thus increasingly recognized as potential therapeutic targets. Blood from young mice reverses aspects of aging and disease across multiple tissues 2-10 , which supports a Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:

No abstract

Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animalsC57Bl/6 male mice, aged (19 months from NIA rodent colony), young (3 months from Charles River or Jackson Labs) Wild animalsThis study did not involve wild animals.Field-collected samples This study did not involve field-collected samples. Ethics oversightInstitutional Animal Care and Use Committee at Stanford University Note that full information on the approval of the study protocol must also be provided in the manuscript. Human research participantsPolicy information about studies involving human research participants Population characteristicsMale and female aged (58-93 years old) cognitively normal and clinically-diagnosed Alzheimer's disease patients. Cognitively normal patients do not display atypical vascular pathologies. Patients are mixed in APOE genotype. RecruitmentSubjects were not recruited specifically for this study. Samples are derived from a brain bank maintained by the Stanford/ VA/ NIA Aging Clinical Research Center (ACRC) from patients that provide consent for broad, de-identified data sharing under Institutional Review Board (IRB) approval. Ethics oversightStanford/ VA/ NIA Aging Clinical Research Center (ACRC) Note that full information on the approval of the study protocol must also be provided in the manuscript.